ArticleInternational urology and nephrology2025

Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma.

Yuki Nemoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.